Inform Diagnostics, a leading national pathology lab, has launched the Paige FullFocus™ digital pathology viewer in its laboratories. Adoption of the new technology allows pathologists at Inform Diagnostics to use intuitive tools, streamline logistics, and achieve faster turnaround times of results.
FullFocus™ is a secure, scalable, intuitive, and responsive viewer for digital pathology slides, and a data management solution for storing the slides.
“This is a tremendous milestone in the company’s history, said Inform Diagnostics CEO Darryl Goss. As an organization committed to putting patients first, FullFocus™ will enable pathologists to gain better insights from samples and provide results to clinicians and their patients quicker. The viewer brings us closer to our vision of being the trusted partner of choice at the forefront of technological innovation in patient diagnostics.”
According to Anuradha Singhal, MD., Chief Medical Officer at Inform Diagnostics, there are multiple benefits associated with using FullFocus™:
- Remote internal and client pathologists can sign out cases from digital images without waiting for glass slides to be shipped.
- Digital archiving/storage allows for instant access to the images of past cases.
- Multiple pathologists can review images simultaneously for added quality assurance
“We are excited to partner with Inform Diagnostics as they digitize their pathology workflows to deliver better clinical insights to clinicians and ultimately their patients,” said Andy Moye, Ph.D., Chief Executive Officer at Paige. “The deployment of FullFocus is a testament to the scalability of Paige’s software and capabilities to support the needs of a large commercial operation.”
FullFocus™ has received FDA clearance for its viewer software and Paige is also the first software company in the United States to receive FDA approval for AI software in digital pathology (Paige Prostate).
About Inform Diagnostics
Inform Diagnostics is one of the largest independent pathology laboratory businesses in the U.S. With exceptional quality and experience, Inform Diagnostics provides subspecialty pathologist‐to‐physician interaction with timely, definitive patient diagnoses in gastrointestinal pathology, dermatopathology, hematopathology, neuropathology, breast pathology, molecular diagnostics (Covid-19 Testing), and genitourinary pathology. Inform Diagnostics is profoundly impacting patient care, one diagnosis at a time, by practicing medicine at the intersection of quality, service, and solutions. The company is headquartered in Irving, Texas, with additional state‐of‐the‐art laboratories in Boston, New York City, and Phoenix. Visit us at informdiagnostics.com.
Paige was founded in 2017 by Thomas Fuchs, Dr.Sc., David Klimstra, M.D., and colleagues from Memorial Sloan Kettering Cancer Center (MSK). The company builds computational pathology products designed so patients and their care teams can make effective, more informed treatment decisions. With this new class of AI-based technologies positioned to drive the future of diagnostics, Paige created a platform to deliver this novel technology to pathologists to transform their workflow and increase diagnostic confidence and productivity. Paige’s products deliver insights to pathologists and oncologists so they can arrive efficiently at more precise diagnoses for patients. Paige is the first company to receive FDA approval for an AI-based digital pathology product. For additional information, please visit: paige.ai.